Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.
Some people have skipped care because of finances or fear of the virus, doctors say. Others find medical practices closed to new patients. Many are suffering health consequences, an NPR poll finds.
The Centers for Disease Control and Prevention released plans for the distribution of coronavirus vaccines. The logistical challenges could be as daunting as the scientific ones.
NPR's Mary Louise Kelly talks with Dr. Atul Gawande, who writes for The New Yorker, about the problem the U.S. is facing with coronavirus testing and what can be done to solve it.
Scientists are racing to develop a vaccine that proves "safe and effective." It may not prevent infection in everyone who gets it, but it still could eventually stop the pandemic. Here's how.
Some pharmaceutical companies are well into the final phase of clinical trials for a coronavirus vaccine. But efforts to recruit patients from minority groups are just beginning.
The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.
There are dividing lines when it comes to how families are weathering the pandemic: Those living in big cities, those making less than $100,000 a year, and Latino and Black families are faring worst.
In major cities, at least 1 in 5 Americans reported being unable to get medical care or delaying medical care for serious problems due to the pandemic, according to a new poll by NPR and two others.
NPR's Audie Cornish talks with psychologist Dolores Albarracín about how reluctance to get a coronavirus vaccine and anti-vaccination misinformation could affect efforts to combat the pandemic.
AstraZeneca, which is working with the University of Oxford, hasn't said what the illness is. It will try to determine whether the illness is related to the vaccine, or just a chance event.
To reassure the public, nine companies issued a joint statement Tuesday saying they won't seek government approval for their coronavirus vaccines until full safety and effectiveness data are in hand.
An experiment involving some "mighty mice" on the International Space Station could someday help astronauts maintain muscle and bone strength on interplanetary journeys.
